tiprankstipranks
RayzeBio, Inc. (RYZB)
NASDAQ:RYZB
US Market

RayzeBio, Inc. (RYZB) Financial Statements

27 Followers

RayzeBio, Inc. Financial Overview

RayzeBio, Inc.'s market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; RayzeBio, Inc. is scheduled to report earnings on November 13, 2023, and the estimated EPS forecast is $-0.69. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Dec 22Dec 21
Income Statement-
Total Revenue----
Gross Profit----
EBIT----
EBITDA----
Net Income Common Stockholders$ -19.40M---
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 540.17M$ 256.95M$ 296.25M$ 199.17M
Total Assets$ 603.51M$ 305.76M$ 324.78M$ 216.38M
Total Debt$ 9.72M$ 10.01M$ 10.57M$ 9.06M
Net Debt$ -530.45M$ -246.94M$ -285.68M$ -190.11M
Total Liabilities$ 28.19M$ 25.99M$ 20.81M$ 15.05M
Stockholders Equity$ 575.32M$ 279.77M$ 303.96M$ 201.34M
Cash Flow-
Free Cash Flow$ -30.79M---
Operating Cash Flow$ -17.26M---
Investing Cash Flow$ -75.54M---
Financing Cash Flow$ 311.55M---
Currency in USD

RayzeBio, Inc. Earnings and Revenue History

RayzeBio, Inc. Debt to Assets

RayzeBio, Inc. Cash Flow

RayzeBio, Inc. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis